UnitedHealth Group (NYSE:UNH) Given New $560.00 Price Target at Barclays

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price objective cut by equities research analysts at Barclays from $642.00 to $560.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has an "overweight" rating on the healthcare conglomerate's stock. Barclays's price target would indicate a potential upside of 33.91% from the company's current price.

A number of other equities research analysts also recently weighed in on UNH. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Mizuho boosted their target price on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Piper Sandler decreased their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Raymond James reissued a "strong-buy" rating and issued a $540.00 price objective (down from $635.00) on shares of UnitedHealth Group in a research note on Monday. Three research analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $603.05.

UnitedHealth Group Stock Down 1.4 %

Shares of UNH traded down $6.05 during mid-day trading on Monday, reaching $418.20. The company's stock had a trading volume of 9,255,934 shares, compared to its average volume of 4,474,528. The business has a fifty day moving average of $504.95 and a 200 day moving average of $536.14. The company has a market cap of $382.53 billion, a price-to-earnings ratio of 26.98, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a 1 year low of $412.10 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the business posted $6.91 earnings per share. As a group, analysts forecast that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.

Institutional Trading of UnitedHealth Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in UNH. West Bancorporation Inc. boosted its holdings in UnitedHealth Group by 12.4% during the first quarter. West Bancorporation Inc. now owns 763 shares of the healthcare conglomerate's stock valued at $400,000 after purchasing an additional 84 shares in the last quarter. Alta Advisers Ltd grew its position in UnitedHealth Group by 49.1% in the first quarter. Alta Advisers Ltd now owns 4,557 shares of the healthcare conglomerate's stock valued at $2,387,000 after acquiring an additional 1,500 shares during the period. Deseret Mutual Benefit Administrators grew its holdings in shares of UnitedHealth Group by 5.2% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 1,083 shares of the healthcare conglomerate's stock worth $567,000 after purchasing an additional 54 shares during the last quarter. Smallwood Wealth Investment Management LLC bought a new position in UnitedHealth Group during the 1st quarter valued at about $107,000. Finally, Saxon Interests Inc. grew its stake in UnitedHealth Group by 3.8% during the first quarter. Saxon Interests Inc. now owns 3,566 shares of the healthcare conglomerate's stock worth $1,868,000 after buying an additional 129 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.